Tag

Doxypep

All articles tagged with #doxypep

health1 year ago

DoxyPEP Roll-Out Reduces STI Rates in Major US City

San Francisco's implementation of DoxyPEP, a single-dose antibiotic for STI prevention, has led to a 58% decrease in STIs among gay men and trans women. The CDC has approved the treatment, and real-world results align with trial data, showing promising outcomes in reducing STI rates. However, its effectiveness in reducing gonorrhea and chlamydia levels needs further research. The new tool is seen as an exciting addition to existing STI prevention strategies.

health-care2 years ago

CDC Releases Updated Guidance to Prevent Spread of STIs

The Centers for Disease Control and Prevention (CDC) has proposed new guidance recommending the prescription of a single 200 mg dose of the antibiotic doxycycline 72 hours after unprotected sex to reduce the spread of common sexually transmitted infections (STIs) such as chlamydia, syphilis, and gonorrhea among at-risk groups including gay and bisexual men and transgender women. Public health experts support this guidance, citing evidence of its benefits. However, concerns have been raised about the potential for antibiotic resistance. The CDC will monitor the situation, and a public comment period has been opened for the proposed rule.

health2 years ago

"Breakthrough STI Prevention Drug: Unveiling the Hidden Trade-off"

The United States is preparing to introduce a new preventative pill called DoxyPEP, which repurposes the antibiotic doxycycline to significantly reduce the risk of chlamydia, gonorrhea, and syphilis after condomless sex. The Center for Disease Control and Prevention (CDC) is developing national guidance for clinicians, but concerns about antibiotic resistance remain. The recommendations will likely target high-risk groups such as gay men and transgender women. Reported cases of these STIs have been on the rise, partly due to decreased condom use and increased identification through regular screening. DoxyPEP has shown efficacy in reducing infections, particularly for chlamydia and syphilis, with minimal side effects. While concerns about antibiotic resistance exist, early research suggests that broadening access to doxycycline may actually promote responsible antibiotic stewardship. Longer-term studies are needed to assess the impact on STIs and other bacteria.

health2 years ago

"Revolutionary Solution: DoxyPEP as an STD Prevention Alternative to Condoms"

Public health officials are considering the use of a common antibiotic, doxycycline, as a morning-after pill to prevent sexually transmitted infections (STIs). Studies have shown that taking doxycycline after sexual encounters can reduce the risk of contracting syphilis, gonorrhea, and chlamydia. However, there are concerns about unintended consequences, such as antibiotic resistance. The Centers for Disease Control and Prevention (CDC) plans to release guidelines for the use of this treatment, known as DoxyPEP, later this summer. While some experts believe it is a much-needed solution to the rising rates of STIs, others argue that more research is needed to understand its long-term effects. Additionally, there are concerns about equitable distribution and disparities in access to the medication.